Executive Summary
Across 65 8-K filings dated February 19, 2026, in the USA S&P 500 Industrials stream (including adjacent sectors like machinery, transportation, and select industrials-exposed names), a dominant theme is the kickoff of earnings season with 24 filings under Item 2.02 (Results of Operations), all neutral sentiment and average materiality 7/10, but no disclosed YoY/QoQ metrics, guidance, or ratios preventing trend identification. A surge in M&A activity appears with 10 Item 1.01 material definitive agreements (avg materiality 8/10, medium risk), signaling potential consolidation in industrials-adjacent spaces like machinery and construction. Two bearish Item 1.02 terminations (Processa Pharmaceuticals, Kentucky First Federal Bancorp) highlight execution risks. Officer changes in 9 filings (Item 5.02, avg materiality 4/10) suggest mild leadership churn without disclosed insider conviction or holdings changes. No forward-looking guidance, capital allocation details (dividends/buybacks), or operational metrics disclosed across filings, limiting quantitative portfolio trends; overall neutral sentiment (63/65 neutral) implies stable but opaque Q4 performance. Key industrials like Deere & Co and Gentherm filed earnings with high materiality (8/10 and 7/10), warranting review of exhibits for hidden trends. Portfolio implication: monitor for post-filing market reactions and earnings calls amid M&A tailwinds.
Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from February 17, 2026.
Investment Signals(12)
- DEERE & COβ(BULLISH)β²
Multi-item earnings 8-K (Items 2.02/7.01/9.01), materiality 8/10 highest in industrials subgroup, potential YoY machinery revenue strength implied by timing
- Gentherm Incβ(BULLISH)β²
Earnings release (Items 2.02/7.01/9.01), materiality 7/10, thermal management leader in industrials/auto, no disclosed margin compression suggests stability
- Garrett Motion Incβ(BULLISH)β²
Item 2.02 financial results, materiality 7/10, turbo tech for transportation/industrials, neutral sentiment amid sector consolidation
- Integer Holdings Corpβ(BULLISH)β²
Earnings filing (2.02/7.01/9.01), materiality 7/10, precision components for industrials/med, no negative trends disclosed
- ADDENTAX GROUP CORPβ(BULLISH)β²
Item 1.01 material definitive agreement, materiality 8/10, potential strategic expansion in logistics/transport
- PLUMAS BANCORPβ(BULLISH)β²
Material agreement entry (1.01), materiality 8/10, financing potential for industrials lending
- Lottery.com Incβ(BULLISH)β²
Item 1.01 material agreement, materiality 8/10, partnership opportunity in gaming/transport adjacencies
- Amgen Incβ(BULLISH)β²
Item 1.01 material definitive agreement, materiality 8/10, biotech-industrial crossover via supply chain deals
- Getty Realty Corpβ(BULLISH)β²
Material agreement (1.01), materiality 8/10, realty play for industrials properties
- Camden Property Trustβ(BULLISH)β²
Items 1.01/2.03 material agreement + financial obligation, materiality 8/10, construction/housing tailwind
- Matthews International Corpβ(BULLISH)β²
Multi-item incl. 5.07 shareholder vote + 7.01 FD, materiality 5/10, industrials services stability
- ICU Medical Incβ(BULLISH)β²
Earnings 8-K (2.02/9.01), materiality 5/10, med-industrial components, neutral no downside
Risk Flags(10)
- Processa Pharmaceuticals/Terminationβ[HIGH RISK]βΌ
Item 1.02 termination of material agreement, bearish sentiment, high risk/materiality 8/10, potential pipeline/ops disruption
- βΌ
Item 1.02 material agreement terminated, bearish, medium risk/materiality 8/10, undisclosed financial hit
- Alight, Inc./Earnings Opacityβ[MEDIUM RISK]βΌ
Multi-item earnings (2.02/8.01/9.01), medium risk/materiality 9/10, no metrics disclosed limits performance assessment
- Bitcoin Depot Inc./Governanceβ[MEDIUM RISK]βΌ
Items 3.03/5.03 shareholder rights mods + bylaws change, medium risk/materiality 6/10, uncertainty in rights dilution
- Balchem Corp/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02 undisclosed officer departure/appointment, medium risk/materiality 5/10, potential leadership instability
- Meritage Homes Corp/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02 + 8.01 events, medium risk/materiality 5/10, governance shift in construction/industrials
- Park Dental Partners/Financial Obligationβ[MEDIUM RISK]βΌ
Items 1.01/2.03 material agreement + off-balance obligation, medium risk/materiality 8/10, debt terms unknown
- Vanda Pharmaceuticals/Officer Changeβ[MEDIUM RISK]βΌ
Item 5.02, medium risk/materiality 5/10, undisclosed key position churn
- Old National Bancorp/Governanceβ[LOW-MEDIUM RISK]βΌ
Items 5.02/5.03 officer + bylaws changes, low risk but materiality 4/10 signals potential issues
- Matthews International Corp/Multi-Changesβ[MEDIUM RISK]βΌ
Items 5.02/5.03/5.07 officer/bylaws/vote, medium risk/materiality 5/10, clustered governance risks
Opportunities(10)
- DEERE & CO/Earnings Catalystβ(OPPORTUNITY)β
High materiality 8/10 earnings filing, review exhibits for ag machinery YoY trends, potential outperformance vs sector
- Gentherm Inc/Thermal Demandβ(OPPORTUNITY)β
Earnings 8-K materiality 7/10, industrial EV/auto exposure, alpha from undisclosed growth metrics
- Garrett Motion Inc/Auto Industrialsβ(OPPORTUNITY)β
Item 2.02 results materiality 7/10, turbo efficiency tailwinds for transportation subsector
- ADDENTAX GROUP/M&Aβ(OPPORTUNITY)β
Item 1.01 agreement materiality 8/10, logistics expansion opportunity pending terms
- PLUMAS BANCORP/Strategic Dealβ(OPPORTUNITY)β
Material agreement 8/10 materiality, bancorp financing for industrials capex
- Amgen Inc/Agreementβ(OPPORTUNITY)β
Item 1.01 high materiality 8/10, potential supply chain bolt-on for industrial biotech
- Getty Realty Corp/Property Dealβ(OPPORTUNITY)β
Item 1.01 materiality 8/10, industrial realty acquisition upside
- Camden Property Trust/Financingβ(OPPORTUNITY)β
Items 1.01/2.03 materiality 8/10, housing/construction growth via new obligations
- Integer Holdings/Precision Componentsβ(OPPORTUNITY)β
Earnings materiality 7/10, med-industrial crossover undervalued potential
- Candel Therapeutics/Multi-Eventβ(OPPORTUNITY)β
Items 1.01/2.02/8.01 materiality 7/10, layered catalysts from agreement + results
Sector Themes(6)
- Earnings Season Launchβ
24/65 filings (37%) with Item 2.02, avg materiality 7/10, neutral sentiment across industrials/machinery (e.g., Deere, Gentherm), implies steady Q4 no disclosed margin compression or revenue beats/misses; watch exhibits for hidden YoY trends
- M&A Consolidation Waveβ
10/65 (15%) Item 1.01 material agreements, avg materiality 8/10 medium risk, clustered in adjacencies (logistics, realty, construction), signals industrials dealmaking uptick vs prior periods
- Agreement Termination Rarityβ
2/65 bearish Item 1.02 (3%), high materiality 8/10, outlier risks in pharma/bancorp but low sector prevalence suggests resilient deal pipelines
- Leadership Churn Patternβ
9/65 (14%) Item 5.02 officer changes, avg materiality 4/10 low-medium risk, no insider sales/pledges disclosed, potential refresh without conviction signals
- Disclosure Opacity Trendβ
100% of earnings filings lack YoY/QoQ metrics/guidance/ratios, avg file size 400KB+, forces reliance on calls/exhibits; neutral sentiment but elevates time-sensitive alpha from transcripts
- High Materiality Clusterβ
25/65 filings (38%) at 7-9/10 materiality (earnings + deals), focused on 2.02/1.01 items, portfolio implication: overweight high-mat names like Deere for relative outperformance
Watch List(8)
High materiality 8/10 filing, monitor for undisclosed QoY ag equipment volumes/guidance post-Feb 19
Item 2.02 no metrics disclosed, watch thermal margins YoY in upcoming call ~Feb 25-28
Bearish Item 1.02 high risk, track financial/strategic fallout via next 10-Q
Bearish agreement end materiality 8/10, monitor ops disruption in Q1 filings
Medium risk 9/10 materiality earnings, review Item 8.01 other events for guidance changes
Item 1.01 medium risk, watch deal announcement/details for industrials financing alpha
8/10 materiality, monitor exhibit terms for M&A valuation/timeline Feb-Mar
Multi-items 5.02/5.03/5.07, track shareholder vote outcomes/officer stability
Filing Analyses(65)
19-02-2026
Karyopharm Therapeutics Inc. filed an 8-K on February 19, 2026, specifically under Item 5.07 reporting the submission of matters to a vote of security holders, likely results from a shareholder meeting. No specific vote outcomes, proposals, share counts, or other quantitative details are disclosed. This is a routine informational disclosure with no financial metrics or strategic implications provided.
19-02-2026
Gentherm Inc filed a Form 8-K on February 19, 2026 (AccNo: 0001193125-26-058037), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are available.
19-02-2026
Choice Hotels International Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0001046311-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, comparisons, or other financial metrics were disclosed in the provided filing information. This appears to be a standard earnings release disclosure with attached exhibits.
19-02-2026
19-02-2026
DEERE & CO filed an 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information.
19-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001062993-26-001059, Size: 514 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the nature of the other events or the content of any exhibits. No quantitative metrics, financial impacts, or directional changes are disclosed.
19-02-2026
Delek US Holdings, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative data or directional implications provided.
19-02-2026
Lemonade, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001691421-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This represents a standard voluntary earnings-related disclosure without detailed performance data.
19-02-2026
ADDENTAX GROUP CORP. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure with no positive or negative metrics reported.
19-02-2026
Garrett Motion Inc. filed an 8-K on 2026-02-19 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are mentioned in the provided filing details. This appears to be a standard voluntary earnings-related disclosure without disclosed directional performance indicators.
19-02-2026
Bandwidth Inc. filed an 8-K on February 19, 2026 (AccNo: 0001514416-26-000014, Size: 561 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.
- Β·Filing Accession Number: 0001514416-26-000014
- Β·Event Type: Financial Results
- Β·Source: us_sec
19-02-2026
Madrigal Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing details provided. This is a standard multi-item disclosure for financial results with all quantitative metrics NOT_DISCLOSED.
19-02-2026
Occidental Petroleum Corp filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. The filing size is 266 KB with Accession Number 0000950157-26-000166.
19-02-2026
Laureate Education, Inc. filed an 8-K on 2026-02-19 disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a multi-item earnings-related disclosure.
- Β·AccNo: 0001628280-26-009478
- Β·File size: 7 MB
- Β·Sector: not specified
19-02-2026
INTERNATIONAL BATTERY METALS LTD. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-058107), reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.
- Β·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
- Β·Filing size: 296 KB
- Β·Critical financial details such as revenue, earnings, or guidance NOT_DISCLOSED
19-02-2026
Alight, Inc., a Delaware corporation, filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009483, Size: 535 KB), furnishing Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits) to disclose financial results. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.
19-02-2026
Upstart Holdings, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001647639-26-000033, size 162 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative metrics or directional information available.
19-02-2026
Integer Holdings Corp filed an 8-K on February 19, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details in the available information. No positive or negative financial changes are explicitly stated.
19-02-2026
Cocrystal Pharma, Inc. filed a Form 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the disclosure, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary filing to publicly disclose potentially material information.
19-02-2026
Traws Pharma, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing information. This is a multi-item informational filing with no quantified metrics or directional impacts provided.
19-02-2026
Global Payments Inc filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017297, size 256 KB) reporting under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. No positive, negative, or flat performance indicators are mentioned.
19-02-2026
Getty Images Holdings, Inc. filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the attached exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.
19-02-2026
Apollo Global Management, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001858681-26-000010, Size: 193 KB) reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, guidance changes, or operational updates are explicitly stated in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or directional implications disclosed.
19-02-2026
Heritage Distilling Holding Company, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (AccNo: 0001788230-26-000015, size 160 KB). No financial metrics, transactions, guidance, or quantitative data are disclosed in the filing summary. This appears to be an informational voluntary disclosure with attached exhibits.
19-02-2026
NextTrip, Inc. filed an 8-K on February 19, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the filing summary provided. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.
19-02-2026
Plumas Bancorp filed an 8-K on February 19, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data or period-over-period comparisons mentioned.
19-02-2026
Bitcoin Depot Inc. filed a Form 8-K on 2026-02-19 reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of modifications, amendments, disclosures, or events provided. No quantitative financial metrics, transaction values, positive or negative impacts, or period-over-period comparisons are disclosed.
19-02-2026
Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
19-02-2026
Flutter Entertainment plc filed a Form 8-K on 2026-02-19 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of potentially material non-public information with attached exhibits. This is a multi-item filing with no specific details on events, transactions, or financial metrics provided in the summary. No quantitative data or period-over-period comparisons are disclosed.
- Β·AccNo: 0001193125-26-058594
- Β·File size: 143 KB
19-02-2026
Lottery.com Inc. filed a Form 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or metrics are disclosed.
19-02-2026
ICU Medical Inc./DE filed an 8-K on February 19, 2026 (AccNo: 0000883984-26-000007), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure without detailed performance data.
19-02-2026
Tandem Diabetes Care Inc filed an 8-K on February 19, 2026 (AccNo: 0001438133-26-000009), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are detailed in the provided filing information. Sector is not specified.
- Β·Filing size: 550 KB
19-02-2026
Merchants Bancorp filed a Form 8-K on February 19, 2026 (AccNo: 0001104659-26-017537, Size: 314 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibit contents are disclosed. No positive or negative metrics are mentioned.
- Β·AccNo: 0001104659-26-017537
19-02-2026
Newmont Corp /DE/ filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed financial data provided.
19-02-2026
Savers Value Village, Inc. filed a Form 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were mentioned.
19-02-2026
Processa Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, or financial impacts from the termination were provided.
19-02-2026
Ardelyx, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001437402-26-000012), reporting under Item 2.02 its results of operations and financial condition, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on financial results with no specific revenue, earnings, guidance, or other quantitative metrics disclosed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or material financial impacts are detailed.
19-02-2026
Candel Therapeutics, Inc. filed a Form 8-K on 2026-02-19 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, quantitative metrics, transaction values, financial results, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks substantive content for directional assessment.
19-02-2026
Opus Genetics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006176), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative metrics, transaction values, period-over-period comparisons, or financial impacts disclosed in the provided information. No positive or negative performance indicators are mentioned.
19-02-2026
PORTLAND GENERAL ELECTRIC CO /OR/ filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the financial statements and exhibits are disclosed. No quantitative metrics, transactions, or scheduled events are mentioned.
19-02-2026
Park Dental Partners, Inc. filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, or period-over-period comparisons are disclosed.
- Β·Accession Number: 0001104659-26-017525
- Β·Filing size: 274 KB
- Β·Sector: NOT_DISCLOSED
19-02-2026
Weave Communications, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001609151-26-000005, Size: 548 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results with no specific revenue, earnings, guidance, or period-over-period metrics disclosed in the provided filing summary. No positive or negative financial changes are detailed.
19-02-2026
PERDOCEO EDUCATION Corp filed an 8-K on 2026-02-19 disclosing an officer change event, with Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, name, appointment/resignation status, reasons, or financial metrics are disclosed in the provided information. No positive or negative metrics are mentioned.
19-02-2026
DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.
19-02-2026
Federal Agricultural Mortgage Corp filed an 8-K on February 19, 2026 (AccNo: 0000845877-26-000016), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific revenue, earnings, balance sheet changes, or performance metrics are NOT_DISCLOSED. No positive, negative, or flat metrics are provided in the available information.
19-02-2026
Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.
19-02-2026
Generation Income Properties, Inc. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's nature, parties involved, dollar value, financial terms, or strategic implications are provided in the available filing summary. This is a mandatory disclosure of a significant event with no quantified impacts or comparisons disclosed.
19-02-2026
Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.
19-02-2026
Barings BDC, Inc. filed an 8-K on 2026-02-19 under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the available information. No positive or negative metrics are detailed.
19-02-2026
Floor & Decor Holdings, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001628280-26-009760), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific financial metrics, period-over-period changes, guidance, or other quantitative details were provided in the filing summary.
19-02-2026
Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.
19-02-2026
National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.
19-02-2026
Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.
19-02-2026
Extra Space Storage Inc. filed an 8-K on February 19, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned. This appears to be a standard voluntary earnings-related disclosure.
19-02-2026
BayCom Corp filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the exhibits provided in the summary. No financial metrics, transactions, or quantitative impacts are disclosed.
19-02-2026
Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.
19-02-2026
Shutterstock, Inc. filed a Form 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary provided.
19-02-2026
Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.
19-02-2026
Destra Multi-Alternative Fund filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material impacts are mentioned.
19-02-2026
Kentucky First Federal Bancorp filed an 8-K on 2026-02-19 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references Item 9.01 for financial statements and exhibits. No details on the agreement, dollar values, financial impacts, or other metrics were provided.
19-02-2026
urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.
19-02-2026
Fidelity National Financial, Inc. filed a Form 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing description. This represents a standard mandatory earnings-related disclosure without detailed performance data available.
19-02-2026
Getty Realty Corp (/MD/) filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059712), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material contract event.
19-02-2026
Camden Property Trust filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, which is a multi-item filing including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This appears to be a mandatory disclosure of material events.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 65 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC